Noubar Afeyan: Explore what we call polyintelligence
Noubar Afeyan, Founder and CEO at Flagship Pioneering, shared a post on LinkedIn:
“Nature’s adaptive genius has long been a fascination of mine. With the rapid rise of AI, I have been pondering the notion of intelligence, in all its forms.
In my 2025 Annual Letter, I explore what we call polyintelligence: the synthesis of human, machine, and nature’s intelligence and how harnessing their interconnections stands to reshape the nature of discovery itself. I hope you will read it and share your thoughts.”
Noubar Afeyan is the CEO of Flagship Pioneering and Board Chairman of Moderna. With a record of over 70 startups, he’s a pioneer in life science and technology. Before Flagship, he founded PerSeptive Biosystems, which reached $100 million in annual revenues. Post-acquisition, he served as senior vice president and chief business officer of Applera, catalyzing Celera Genomics’ creation. He is also co-founder and Board Chairman of Generate:Biomedicines, Tessera Therapeutics, Alltrna, Apriori Bio, and ProFound Therapeutics.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023